APA (7th ed.) Citation

S, S., AI, R., R, B., KL, H., & JB, G. (2018). Biologic prescribing decisions following serious infection: Results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis. Rheumatology (Oxford, England), 57(12), 2096. https://doi.org/10.1093/rheumatology/key198

Chicago Style (17th ed.) Citation

S, Subesinghe, Rutherford AI, Byng-Maddick R, Hyrich KL, and Galloway JB. "Biologic Prescribing Decisions Following Serious Infection: Results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis." Rheumatology (Oxford, England) 57, no. 12 (2018): 2096. https://doi.org/10.1093/rheumatology/key198.

MLA (9th ed.) Citation

S, Subesinghe, et al. "Biologic Prescribing Decisions Following Serious Infection: Results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis." Rheumatology (Oxford, England), vol. 57, no. 12, 2018, p. 2096, https://doi.org/10.1093/rheumatology/key198.